EFPIA supports the EU Biotechnology Law and a 12-month SPC extension but warns the current proposal is too limited. A broader scope could attract up to...
EFPIA’s new report urges clearer, lifecycle-wide governance for AI in pharmaceuticals. Drawing on cross-sector insights, it calls for clarifying AI exemptions, strengthening regulator–industry dialogue, harmonizing expectations,...